Dr. Kyle Spencer Jackson, DMD,DHSC Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 301 Saddle Dr, Suite A, Helena, MT 59601 Phone: 406-442-1899 |
George B Givler, DDS Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 65 Medical Park Dr, Helena, MT 59601 Phone: 406-443-3334 Fax: 406-443-3335 |
Kevin L Rencher, DDS Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 251 Saddle Dr, Helena, MT 59601 Phone: 406-449-0189 Fax: 406-449-7237 |
Dr. Phillip Quinn Lybbert, D.M.D. Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 2728 Colonial Dr Ste 201, Helena, MT 59601 Phone: 406-422-8589 Fax: 406-513-1025 |
Paul K Nielsen, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2619 Colonial Dr, Ste B, Helena, MT 59601 Phone: 406-442-7831 Fax: 406-442-7893 |
Tedi J Howell, DMD Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 3116 Saddle Dr Ste 1, Helena, MT 59601 Phone: 406-449-0189 |
Dr. Leonard William Keppler Jr., DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2600 Winne Ave Suite E, Helena, MT 59601 Phone: 406-442-8062 |
News Archive
Selonterra LLC, a biotechnology company discovering therapies for Alzheimer's disease and Parkinson's disease announced the publication of the article "Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer's Disease" in Scientific Reports, a peer-reviewed journal of the Nature Publishing Group.
This new vaccine which could become available in the United States in the next few years, is made by growing the influenza virus in cultures of animal cells rather than in the chicken eggs that have been used for more than five decades. This shortens the process by six months. Using animal cells, which are grown in enclosed steel tanks, also reduces the risk of bacterial contamination, which has led to shortages of seasonal vaccines in some years. The study was reported in The Lancet this Tuesday.
Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.
According to a recent study from the University and the University Central Hospital of Helsinki, Finland, no allergy-preventive effect is extended to age 5 years by perinatal supplementation with probiotics in babies at risk for developing allergies; protection is conferred only to Cesarean section babies.
› Verified 3 days ago